Over-the-Counter (OTC) Drugs Market Size By Product (Analgesics, Cold, Cough & Flu Products, Weight Loss Products, Gastrointestinal Products, Skin Products, Mineral and Vitamin Supplements, Sleeping Aids, Ophthalmic Products), Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Feb 2019  |  Report ID: GMI1884  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 128   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition & forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Over-the-counter (OTC) drugs industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Regional trends

Chapter 3. Over-the-counter (OTC) Drugs Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Pharmaceutical companies switching from Rx to OTC drugs especially in the U.S

3.3.1.2. Growing trend of self-medication in developing economies

3.3.1.3. Significant cost savings due to OTC drug usage in Asia pacific and Latin America

3.3.2. Industry pitfalls & challenges

3.3.2.1. Several concerns pertaining to incorrect diagnosis and substance abuse

3.4. Growth potential analysis

3.4.1. By product

3.5. Regulatory landscape

3.5.1. U.S.

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2017

3.7.1. Business overview

3.7.2. Revenue analysis

3.7.3. Product landscape

3.7.4. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Over-the-counter (OTC) Drugs Market, By Product

4.1. Key segment trends

4.2. Analgesics

4.2.1. Market estimates and forecast, by region, 2014 - 2025

4.3. Cold, cough & flu products

4.3.1. Market estimates and forecast, by region, 2014 - 2025

4.4. Weight loss products

4.4.1. Market estimates and forecast, by region, 2014 - 2025

4.5. Gastrointestinal products

4.5.1. Market estimates and forecast, by region, 2014 - 2025

4.6. Skin products

4.6.1. Market estimates and forecast, by region, 2014 - 2025

4.7. Mineral and vitamin supplements

4.7.1. Market estimates and forecast, by region, 2014 - 2025

4.8. Sleeping aids

4.8.1. Market estimates and forecast, by region, 2014 - 2025

4.9. Ophthalmic products

4.9.1. Market estimates and forecast, by region, 2014 - 2025

4.10. Others

4.10.1. Market estimates and forecast, by region, 2014 - 2025

Chapter 5. Over-the-counter (OTC) Drugs Market, By Region

5.1. Key regional trends

5.2. North America

5.2.1. Market estimates and forecast, by country, 2014 - 2025

5.2.2. Market estimates and forecast, by product, 2014 - 2025

5.2.3. U.S.

5.2.3.1. Market estimates and forecast, by product, 2014 - 2025

5.2.4. Canada

5.2.4.1. Market estimates and forecast, by product, 2014 - 2025

5.3. Europe

5.3.1. Market estimates and forecast, by country, 2014 - 2025

5.3.2. Market estimates and forecast, by product, 2014 - 2025

5.3.3. Germany

5.3.3.1. Market estimates and forecast, by product, 2014 - 2025

5.3.4. UK

5.3.4.1. Market estimates and forecast, by product, 2014 - 2025

5.3.5. France

5.3.5.1. Market estimates and forecast, by product, 2014 - 2025

5.3.6. Italy

5.3.6.1. Market estimates and forecast, by product, 2014 - 2025

5.3.7. Spain

5.3.7.1. Market estimates and forecast, by product, 2014 - 2025

5.3.8. Russia

5.3.8.1. Market estimates and forecast, by product, 2014 - 2025

5.3.9. Poland

5.3.9.1. Market estimates and forecast, by product, 2014 - 2025

5.4. Asia Pacific

5.4.1. Market estimates and forecast, by country, 2014 - 2025

5.4.2. Market estimates and forecast, by product, 2014 - 2025

5.4.3. India

5.4.3.1. Market estimates and forecast, by product, 2014 - 2025

5.4.4. China

5.4.4.1. Market estimates and forecast, by product, 2014 - 2025

5.4.5. Japan

5.4.5.1. Market estimates and forecast, by product, 2014 - 2025

5.4.6. Australia

5.4.6.1. Market estimates and forecast, by product, 2014 - 2025

5.4.7. South Korea

5.4.7.1. Market estimates and forecast, by product, 2014 - 2025

5.4.8. Taiwan

5.4.8.1. Market estimates and forecast, by product, 2014 - 2025

5.5. Latin America

5.5.1. Market estimates and forecast, by country, 2014 - 2025

5.5.2. Market estimates and forecast, by product, 2014 - 2025

5.5.3. Mexico

5.5.3.1. Market estimates and forecast, by product, 2014 - 2025

5.5.4. Brazil

5.5.4.1. Market estimates and forecast, by product, 2014 - 2025

5.5.5. Argentina

5.5.5.1. Market estimates and forecast, by product, 2014 - 2025

5.6. Middle East and Africa

5.6.1. Market estimates and forecast, by country, 2014 - 2025

5.6.2. Market estimates and forecast, by product, 2014 - 2025

5.6.3. South Africa

5.6.3.1. Market estimates and forecast, by product, 2014 - 2025

5.6.4. Saudi Arabia

5.6.4.1. Market estimates and forecast, by product, 2014 - 2025

5.6.5. Kuwait

5.6.5.1. Market estimates and forecast, by product, 2014 - 2025

5.6.6. Qatar

5.6.6.1. Market estimates and forecast, by product, 2013 – 2024

Chapter 6. Company Profiles

6.1. Bayer HealthCare

6.1.1. Business overview

6.1.2. Financial data

6.1.3. Product landscape

6.1.4. Strategic outlook

6.1.5. SWOT analysis

6.2. GlaxoSmithKline (GSK)

6.2.1. Business overview

6.2.2. Financial data

6.2.3. Product landscape

6.2.4. Strategic outlook

6.2.5. SWOT analysis

6.3. Sanofi

6.3.1. Business overview

6.3.2. Financial data

6.3.3. Product landscape

6.3.4. Strategic outlook

6.3.5. SWOT analysis

6.4. Johnson & Johnson

6.4.1. Business overview

6.4.2. Financial data

6.4.3. Product landscape

6.4.4. Strategic outlook

6.4.5. SWOT analysis

6.5. Pfizer

6.5.1. Business overview

6.5.2. Financial data

6.5.3. Product landscape

6.5.4. Strategic outlook

6.5.5. SWOT analysis

6.6. Sun Pharmaceutical Industries Ltd.

6.6.1. Business overview

6.6.2. Financial data

6.6.3. Product landscape

6.6.4. Strategic outlook

6.6.5. SWOT analysis

6.7. Alkem Laboratories Limited

6.7.1. Business overview

6.7.2. Financial data

6.7.3. Product landscape

6.7.4. Strategic outlook

6.7.5. SWOT analysis

6.8. Cipla, Inc.

6.8.1. Business overview

6.8.2. Financial data

6.8.3. Product landscape

6.8.4. Strategic outlook

6.8.5. SWOT analysis

6.9. Teva Pharmaceutical Industries Ltd.

6.9.1. Business overview

6.9.2. Financial data

6.9.3. Product landscape

6.9.4. Strategic outlook

6.9.5. SWOT analysis

6.10. Glenmark Pharmaceuticals Ltd.

6.10.1. Business overview

6.10.2. Financial data

6.10.3. Product landscape

6.10.4. Strategic outlook

6.10.5. SWOT analysis

6.11. Takeda

6.11.1. Business overview

6.11.2. Financial data

6.11.3. Product landscape

6.11.4. Strategic outlook

6.11.5. SWOT analysis

6.12. Innovus Pharmaceutical Inc.

6.12.1. Business overview

6.12.2. Financial data

6.12.3. Product landscape

6.12.4. Strategic outlook

6.12.5. SWOT analysis

6.13. Dr. Reddy's Laboratories

6.13.1. Business overview

6.13.2. Financial data

6.13.3. Product landscape

6.13.4. Strategic outlook

6.13.5. SWOT analysis

6.14. Reckitt Benckiser Group Plc

6.14.1. Business overview

6.14.2. Financial data

6.14.3. Product landscape

6.14.4. Strategic outlook

6.14.5. SWOT analysis

6.15. Piramal

6.15.1. Business overview

6.15.2. Financial data

6.15.3. Product landscape

6.15.4. Strategic outlook

6.15.5. SWOT analysis
 

Data Tables

TABLE 1.    Over-the-counter (OTC) drugs industry 360° synopsis, 2013 – 2024

TABLE 2.    Global OTC drugs market, 2014 – 2025 (USD Billion)

TABLE 3.    Global OTC drugs market, by product, 2014 - 2018 (USD Million)

TABLE 4.    Global OTC drugs market, by product, 2019 - 2025 (USD Million)

TABLE 5.    Global OTC drugs market, by region, 2014 – 2025 (USD Billion)

TABLE 6.    Industry impact forces

TABLE 7.    U.S. FDA prescription to over-the-counter (OTC) switch list

TABLE 8.    Analgesics market size, by region, 2014 – 2018 (USD Billion)

TABLE 9.    Analgesics market size, by region, 2019 – 2025 (USD Billion)

TABLE 10.    Cold, cough and flu market size, by region, 2014 – 2018 (USD Billion)

TABLE 11.    Cold, cough and flu market size, by region, 2019 – 2025 (USD Billion)

TABLE 12.    Weight loss market size, by region, 2014 – 2018 (USD Billion)

TABLE 13.    Weight loss market size, by region, 2019 – 2025 (USD Billion)

TABLE 14.    Gastrointestinal market size, by region, 2014 – 2018 (USD Billion)

TABLE 15.    Gastrointestinal market size, by region, 2019 – 2025 (USD Billion)

TABLE 16.    Skin market size, by region, 2014 – 2018 (USD Billion)

TABLE 17.    Skin market size, by region, 2019 – 2025 (USD Billion)

TABLE 18.    Minerals and vitamins market size, by region, 2014 – 2018 (USD Billion)

TABLE 19.    Minerals and vitamins market size, by region, 2019 – 2025 (USD Billion)

TABLE 20.    Sleeping aids market size, by region, 2014 – 2018 (USD Billion)

TABLE 21.    Sleeping aids market size, by region, 2019 – 2025 (USD Billion)

TABLE 22.    Ophthalmic market size, by region, 2014 – 2018 (USD Billion)

TABLE 23.    Ophthalmic market size, by region, 2019 – 2025 (USD Billion)

TABLE 24.    Others market size, by region, 2014 – 2018 (USD Billion)

TABLE 25.    Others market size, by region, 2019 – 2025 (USD Billion)

TABLE 26.    North America OTC drugs market size, by country, 2014 - 2025 (USD Billion)

TABLE 27.    North America OTC drugs market size, by product, 2014 – 2018 (USD Million)

TABLE 28.    North America OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 29.    U.S. OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 30.    U.S. OTC drugs market size, by product, 2019 – 2025 (USD Million)

TABLE 31.    Canada OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 32.    Canada OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 33.    Europe OTC drugs market size, by country, 2014 - 2025 (USD Billion)

TABLE 34.    Europe OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 35.    Europe OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 36.    Germany OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 37.    Germany OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 38.    UK OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 39.    UK OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 40.    France OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 41.    France OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 42.    Italy OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 43.    Italy OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 44.    Spain OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 45.    Spain OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 46.    Russia OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 47.    Russia OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 48.    Poland OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 49.    Poland OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 50.    Asia Pacific OTC drugs market size, by country, 2014 - 2025 (USD Billion)

TABLE 51.    Asia Pacific OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 52.    Asia Pacific OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 53.    India OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 54.    India OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 55.    China OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 56.    China OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 57.    Japan OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 58.    Japan OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 59.    Australia OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 60.    Australia OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 61.    South Korea OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 62.    South Korea OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 63.    Taiwan OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 64.    Taiwan OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 65.    Latin America OTC drugs market size, by country, 2014 - 2025 (USD Billion)

TABLE 66.    Latin America OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 67.    Latin America OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 68.    Brazil OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 69.    Brazil OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 70.    Mexico OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 71.    Mexico OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 72.    Argentina OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 73.    Argentina OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 74.    Middle East and Africa OTC drugs market size, by country, 2014 - 2025 (USD Billion)

TABLE 75.    Middle East and Africa market size, by product, 2014 - 2025 (USD Billion)

TABLE 76.    South Africa OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 77.    South Africa OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 78.    Saudi Arabia OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 79.    Saudi Arabia OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 80.    Kuwait OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 81.    Kuwait OTC drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 82.    Qatar OTC drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 83.    Qatar OTC drugs market size, by product, 2019 - 2025 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global over-the-counter (OTC) drugs market, 2014- 2025 (USD Million)

FIG. 3    Growth potential analysis, by product

FIG. 4    Porter’s analysis

FIG. 5    PESTEL analysis

FIG. 6    Strategy dashboard

FIG. 7    Over-the-counter (OTC) drugs market share, by product, 2018 & 2025

FIG. 8    Over-the-counter (OTC) drugs market share, by region, 2018 & 2025

 

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X